We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-24.00 | -0.20% | 12,142.00 | 12,138.00 | 12,142.00 | 12,198.00 | 12,114.00 | 12,186.00 | 383,595 | 14:01:56 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.58 | 188.04B |
Date | Subject | Author | Discuss |
---|---|---|---|
23/12/2020 22:23 | I would definitely take it. If you really want to know side effects for any drug or vaccine you can look up the SPC (summary of product characteristics). All licenced drugs have a unique PL number and leaflet. When the vaccine is licenced it will have it too. All drugs have the potential for side effects, go read up on paracetamol and then you probably wont take that too then? Most are rare and benefit outweigh risks otherwise no drugs would ever be licenced | sheunghim | |
23/12/2020 21:55 | Likewise. I'd take it as soon as offered to me, it would sure beat suffering from/dying of Covid or being left with long Covid indefinitely, not to mention the benefit of eventually returning to normality! | bountyhunter | |
23/12/2020 21:43 | Well you could ask the doctor what list of side effects they have for the flu vaccine, I don't think they are listed on the NHS website, I wonder why? | wipo1 | |
23/12/2020 21:04 | I'm sure you meant to say anyone daft enough NOT to take it :-) | gregb | |
23/12/2020 20:29 | Is anyone daft enough to take it? | wipo1 | |
23/12/2020 17:28 | Positive sentiment next week on approval of the Astra vaccine should reverse the recent decline. | bountyhunter | |
23/12/2020 17:09 | Agreed, and you only have to see the small rise in HSBC vs the other Banks gaining 5 to 7%. If you check the charts you can actually see the price movement at about 1420 | triple witcher | |
23/12/2020 16:45 | all AZN shareholders should watch this youtube | ukneonboy | |
23/12/2020 16:40 | The price drop is definitely the strength of the pound. Look at your big caps like GSK, BATs, Unilever, Reckitt Benkiser and Diageo. They all had similar drops today. | sheunghim | |
23/12/2020 16:02 | I think you’ll find it’s the USA buying just ahead of their market opening at 14:30 | adobbing | |
23/12/2020 15:49 | Yes. Definitely is a factor. | essentialinvestor | |
23/12/2020 15:46 | Is there not a correlation between this and GBP/USD? Sterling took a surge up about 14.20 and the share price started to sink, imho, other stocks like banks etc surged upwards at the same time ? | triple witcher | |
23/12/2020 15:25 | Good news, but that not the reason price falling. I think the takeover its massive, now shareprice falling, will they have to offer more cash. | montyhedge | |
23/12/2020 14:22 | just adding on this news.. Astra / oxford vaccine to get approval UK use 28/ 29 Dec, as my local health centre already getting ready Jan 3rd for jabs from astra. It's coming.... lol | onehanded | |
23/12/2020 00:34 | Malaysia inks agreement with AstraZeneca to procure 6.4 Million doses of Covid-19 vaccine | philanderer | |
23/12/2020 00:24 | Market report: While Astrazeneca scientists were frantically testing to see if its vaccine would protect against the mutant Covid strain, it suffered a setback with its experimental drug Amgen. Astra shed 1.5 per cent, or 112p, to 7328p after it failed to meet the goal of a late-stage trial to reduce patients’ dependence on steroids. | philanderer | |
22/12/2020 20:42 | "Oxford Biomedica is manufacturing tens of millions of doses of the vaccine on behalf on AstraZeneca. Production involves various stages, starting with a vial of a frozen master bank of cells, which are thawed out and transferred into larger and larger solutions of media, each time being given time to grow. This takes several weeks until eventually there is enough vaccine to fill a 1,000-litre bioreactor. The solution then goes through a process of separation, purification and concentration before being frozen into 15-litre bags which are stored in special trays, ready to be transferred into individual dose vials at a fill/finish house at a different location." Well worth a read, lots of detail. | bountyhunter | |
22/12/2020 20:41 | Worse still six people died after taking the Moderna vaccine! Give me the Astra Oxford vaccine any day in preference to the Pfizer or Moderna vaccines!! | bountyhunter | |
22/12/2020 19:10 | We need their vaccine ASAP. Another 691 people dead on today's update, nearly 37,000 new cases. | essentialinvestor | |
22/12/2020 18:50 | Macron’s lorry ban is utterly pointless – mutant Covid is already all over Europe The irony is that Britain will soon be riding to rescue the Continent Emmanuel Macron’s ban on lorries entering France wins the prize for the most pointless political gesture since the onset of this pandemic. The mutant strain B.1.1.7 is already across Europe. | coxsmn | |
22/12/2020 18:41 | Steeplejack, Good post, I think it's a mix of things, vaccine, GBP vs USD, Sentiment not good on takeover and I think ppl just not knowing where the bottom is, I would of topped up today but stopped myself. I think when the vaccine gets approved we could see a very powerful surge to £81, I think I would rather wait for the approval and buy into strength at a higher price than try to guess the bottom. Costing me a fortune holding this been buying since £83 and averaging down. The tide will turn, keep the faith! | turvart | |
22/12/2020 17:34 | Truly remarkable how this stock has gone from around £100 to only some 10% off a years low in less than 6 months.Explanations might be proffered aplenty but it’s a real surprise even with a backcloth of rising sterling.In Glaxo’s case,not a complete surprise perhaps but in AZNs case with its drug portfolio it seems fairly churlish.I suppose the Alexion acquisition (with the consequential increased debt and issue of stock)can be be held accountable but the shares were a good 20% off the year’s high even before the deal was announced.I don’t know how quickly the shares will recover because appetite surrounding the stock in the US seems especially weak.Trouble is, US commentary has always suggested that AZNs drug vaccine has proved less ‘successful At this price,you will be hard pressed to find a broker not recommending BUY.The prosp. consensus PE for 2021 is an attractive 20, the PEG is undemanding plus a yield of around 3%.From a chartist point of view,the shares look oversold on RSI but technicals also look uncertain due to the recent thorough going breakdown of support at around £80.These shares are in a bad place and I’m not sure what’s going to meaningfully turn sentiment albeit you might see a short term oversold bounce. | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions